Provided by Tiger Fintech (Singapore) Pte. Ltd.

The Oncology Institute

3.84
-0.1255-3.16%
Volume:664.75K
Turnover:2.55M
Market Cap:378.23M
PE:-5.71
High:3.99
Open:3.97
Low:3.73
Close:3.97
52wk High:4.88
52wk Low:0.1253
Shares:98.38M
Float Shares:82.44M
Volume Ratio:1.03
T/O Rate:0.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6732
EPS(LYR):-0.7063
ROE:-651.69%
ROA:-17.27%
PB:-42.10
PE(LYR):-5.44

Loading ...

Oncology Institute Up Nearly 34%, on Pace for Largest Percent Increase Since June 2023 -- Data Talk

Dow Jones
·
Nov 15

Oncology Institute Shares Jump 10.6% After Q3 Revenue Jump

THOMSON REUTERS
·
Nov 14

Noble Financial Remains a Buy on Oncology Institute (TOI)

TIPRANKS
·
Nov 14

Oncology Institute Shares Jump 13.6% Premarket After Q3 Revenue Jump

THOMSON REUTERS
·
Nov 14

Oncology Institute Shares Climb on Raised FY25 Outlook

Dow Jones
·
Nov 14

Oncology Institute Q3 Consolidated REV of $136.6 Million

THOMSON REUTERS
·
Nov 14

The Oncology Institute Q3 EPS $(0.14) Misses $(0.11) Estimate, Sales $136.564M Beat $122.633M Estimate

Benzinga
·
Nov 14

The Oncology Institute Inc. reports Q3 revenue growth and raises 2025 guidance

Reuters
·
Nov 14

BRIEF-Oncology Institute Q3 Gross Profit USD 18.9 Million

Reuters
·
Nov 14

Oncology Institute Q3 EPS USD -0.14

THOMSON REUTERS
·
Nov 14

Press Release: The Oncology Institute Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance

Dow Jones
·
Nov 14

Ascertain and The Oncology Institute Co-Develop ‘Touchless’ AI Automation for Oncology Administration

GlobeNewswire
·
Nov 14

Oncology Institute Inc - on Nov 3 Co Determined Cybersecurity Incident May Delay Fee-for-Service Collections - SEC Filing

THOMSON REUTERS
·
Nov 07

Oncology Institute Inc - No Evidence of Patient Data Compromise in Incident - SEC Filing

THOMSON REUTERS
·
Nov 07

Oncology Institute (TOI) Gets a Buy from Noble Financial

TIPRANKS
·
Oct 23

The Oncology Institute Announces Third Quarter 2025 Earnings Release Date and Conference Call

GlobeNewswire
·
Oct 23

BTIG Keeps Their Buy Rating on Oncology Institute (TOI)

TIPRANKS
·
Oct 21

Oncology Institute Price Target Maintained With a $7.00/Share by BTIG

Dow Jones
·
Oct 21

BTIG Sticks to Their Buy Rating for Oncology Institute (TOI)

TIPRANKS
·
Oct 02

The Oncology Institute Inc. to Participate in Noble Capital Markets Emerging Growth Virtual Equity Conference

Reuters
·
Oct 01